• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Astellas Culture in one word





















































Scary. 370 plus reps selling one product that way underperformed in a niche market and one of the companies biggest cash cows getting dropped out of nowhere. Six months from now, I'd guess there will be a huge cull with the Salesforce
 








Scary. 370 plus reps selling one product that way underperformed in a niche market and one of the companies biggest cash cows getting dropped out of nowhere. Six months from now, I'd guess there will be a huge cull with the Salesforce
Do you think we will survive past this?? They are so hell bent Veozah being a Billion dollar drug
 








Do you think we will survive past this?? They are so hell bent Veozah being a Billion dollar drug
Billion dollar drug while competing against a therapy that's been gold standard for decades that all residents and fellows are trained how to use?! Against an dual-acting Bayer product that's going to show better efficacy than us in every primary and secondary endpoint and can actually make the significant reduction in sleep disturbance and improvement in quality of life claims that we can't?! To put it plainly, I don't think we stand a snowball's chance in hell!